BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Trials

Otsuka's AVP-786 Falls Short in Phase 3 Trial for Alzheimer's Agitation

Otsuka Pharmaceutical Development & Commercialization, Inc., (OPDC) and its parent company Otsuka Pharmaceutical, Co. Ltd. (Otsuka) have released the t...

February 13, 2024 | News

Gilead Sciences Bolsters Liver Portfolio Through Acquisition of CymaBay Therapeutics

Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced today a definitive agreement whereby Gilead will acquire CymaBay for $32.50 ...

February 13, 2024 | News

CSL Reveals Phase 3 AEGIS-II Trial Results for CSL112

"We look forward to sharing our scientific learnings regarding cholesterol efflux and recurrent cardiovascular events," said C. Michael Gibson, M.S., ...

February 12, 2024 | News

Zymedi initiates first human dosing of ZMA001 in a clinical trial for Pulmonary Arterial Hypertension in South Korea

In collaboration with the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH), Zymedi is conducting this t...

February 09, 2024 | News

SMC Laboratories Unveils STAM™-HCC/IO+ Mouse for Advancing Liver Cancer Drug Development in Immuno-Oncology

The company specializes in liver-related services and has evaluated test substances in over 15 MOA categories as well as over 270 target molecules us...

February 07, 2024 | News

ShiraTronics finishes Australian pilot study enrollment, gears up for pivotal clinical trial

Migraine, recognized globally as a significant cause of disability, particularly among pre-menopausal women, poses a substantial health challenge. For arou...

February 07, 2024 | News

Stakeholders Rally for Sustainable Funding to Secure Australia's Future of National One Stop Shop for Clinical Trials

The NOSS, a pioneering digital platform, seeks to streamline the approval and reporting procedures for human research, particularly clinical trials, in Aus...

February 06, 2024 | News

Genesis MedTech Finishes U.S. Study Enrollment for J-Valve™ in Severe Aortic Regurgitation

Genesis MedTech, a leading medical device company, today announced the completion of enrollment in its United States Early Feasibility Study (EFS) usi...

February 06, 2024 | News

NouvNeu001 Marks Milestone in iRegene's c Trial with Successful First Patient Dosing

It is reported that the multicenter, open-label clinical trial (Phase I/II) is meticulously crafted to systematically evaluate the safety, tolerability, an...

February 06, 2024 | News

Pliant Therapeutics Reports Positive Results in Bexotegrast Trial for Liver Fibrosis

Bexotegrast (PLN-74809) at 320 mg was well tolerated over 12 weeks of treatment with no drug-related severe or serious adverse events; No safety conce...

February 05, 2024 | News

Sirius Therapeutics Begins Phase 1 Trial for Long-Acting Factor XI siRNA Anticoagulant

"This study is based on in vivo studies that have demonstrated a nearly 100% reduction in FXI levels for up to 6 months without bleeding events a...

February 04, 2024 | News

SoniVie Completes Enrollment in REDUCED-1 Pilot Study for TIVUS™ Renal Denervation

SoniVie, an Israeli company developing a novel, proprietary Therapeutic Intra-Vascular Ultrasound (TIVUSTM) System to treat a variety of hypertensive disor...

February 01, 2024 | News

Taiwan's Anbogen Secures $12.5M in Series A for Precision Oncology

The lead investor is China Development Industrial Bank (CDIB), with significant contributions from Taian Venture Capital, Maxpro and the National Developme...

February 01, 2024 | News

Endogenex Receives IDE Approval to Initiate Pivotal Clinical Study

Endogenex, Inc., a clinical stage medical device company dedicated to improving outcomes in patients with Type 2 Diabetes (T2D), announced that the U...

January 31, 2024 | News

Stay Connected